Your email has been successfully added to our mailing list.

×
0 0.00204498977505108 0.00204498977505108 0.0465030674846624 0.073721881390593 0.0879345603271983 0.0879550102249488 0.108752556237219
Stock impact report

BiondVax can continue with its late-stage flu vaccine trial [Seeking Alpha]

BiondVax Pharmaceuticals Ltd. - American Depositary Shares (BVXV) 
US:NASDAQ Investor Relations: biondvax.com/investors
Company Research Source: Seeking Alpha
BiondVax can continue with its late-stage flu vaccine trialBiondVax (NASDAQ:BVXV) will proceed with itsPhase 3 trial plan for its flu vaccine M-001 after receiving advice from a European Medicines Agency committee.The Committee for Medicinal Products for Human Use agreed to the study design and said “a single pivotal efficacy trial that provides a robust demonstration of efficacy against laboratory-proven influenza like illness could suffice for an approval.”The trial will take place in Eastern Europe and start before the 2018/19 flu season.BiondVax shares areup 3.2%.Previously:Biondvax Pharmaceuticals reports Q3 results(Nov. 28)See all stocks on the move »Now read:Global Blood Therapeutics: The Significance Of ASH Updates » Show less Read more
Impact Snapshot
Event Time:
BVXV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BVXV alerts
Opt-in for
BVXV alerts

from News Quantified
Opt-in for
BVXV alerts

from News Quantified